The impact of BNO 1030 on phagocytic activity of white blood cells in rats with type 1 diabetes mellitus
Journal Title: Міжнародний ендокринологічний журнал - Year 2017, Vol 13, Issue 5
Abstract
Background. In the pathogenesis of type 1 diabetes mellitus (DM1) and many of its complications, an important place belongs to a violation of the functional capacity of the immune system, which is the subject of numerous studies. Considering the effectiveness of immunomodulating therapy for DM1 and its complications, one of the most important problems is the search for new effective and harmless immunocorrecting agents with high pharmacological activity. The purpose of this study was to evaluate the effect of the phytopreparation BNO 1030 on the phagocytic activity of blood leukocytes in rats with DM1. Materials and methods. Experimental DM1 in rats was induced by a single intraperitoneal injection of streptozotocin. The percentage of phagocytic cells and macrophage uptake of live fluorescent bacteria in the samples were determined using fluorescent live bacteria Escherichia coli. Results. The effect of the drug BNO 1030 on the phagocytic activity of white blood cells with DM1 in rats was investigated. Under hyperglycemia it was found changes in the redistribution of the main types of leukocytes, namely granulocytes and agranulocytes. The administration of the drug BNO 1030 to both control and diabetic animals resulted in an increase in the number of agranulocytes, which may indicate a modulating effect of the drug on the immune system of animals. Under these conditions, phagocytic activity of leukocytes was decreased as phagocytic number in group of diabetic rats was reduced by 42 % in comparison with group of control animals. BNO 1030 administration to diabetic rats caused an increase of phagocyte number by 24 % compared to the group of diabetic animals. These changes, in turn, are also accompanied by a decrease of phagocytic index as in diabetes, and when drug was administered to experimental groups, indicating disorders in nonspecific cellular immune system. Conclusions. BNO 1030 due to its immunomodulatory effect is effective in the treatment of DM1 and its comorbidity with other chronic diseases.
Authors and Affiliations
Yu. V. Gavrylenko
Keywords
Related Articles
- EP ID EP240175
- DOI 10.22141/2224-0721.13.5.2017.110028
- Views 51
- Downloads 0
Correlation of Hypothyroidism and Obesity
Obesity and hypothyroidism are common diseases, and consequently clinicians should be particularly alert for the possible thyroid dysfunction in obese patients. The relationship between thyroid function and obesity is li...
Features of insulin resistance in patients with long history of type 1 diabetes mellitus, methods of Its correction
Background. A research aim is an estimation of insulin resistance (ІR), and also possibilities of its correction in patients with long-term experience of type 1 diabetes mellitus (DM). Materials and methods. 33 patients...
Efficiency of D2 Receptors Agonists in treatment of Patients with Non-Functional Pituitary Adenoma with Hereditary-Tainted Anamnesis
There were analyzed two clinical cases of non-functional pituitary adenoma with the hereditary-tainted anamnesis. The presence of the original disposition or familial-hereditary cases of non-functional pituitary adenoma...
Insuman in Disposable Pen SoloStar: New Opportunities of insulin therapy in patients with diabetes mellitus
The article shows the importance of glycemic control in patients with diabetes and the role of insulin in maintaining blood glucose at the right level. The characteristic of modern insulins is given, an emphasis was made...
Improving Surgical Techniques of Finger Amputation and Treatment of Patients with Diabetic Foot Syndrome
We have performed surgeries in 31 patients with diabetes mellitus complicated by diabetic foot syndrome of neuropathic and neuroischemic origin. The study group consisted of 11 men aged 60.50 ± 1.50 years and 20 women ag...